Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Glesatinib hydrochloride | 2319837-80-2 | 98.0% | 656.17 | 1 ML
SDP

Catalog No. 5000402795
Encompass_Preferred

Glesatinib hydrochloride is an orally active, potent dual inhibitor of MET and SMO. This tyrosine kinase inhibitor also antagonizes P-glycoprotein (P-gp) mediated multidrug resistance (MDR) in non-small cell lung cancer (NSCLC).

  • Orally active and potent MET/SMO dual inhibitor.
  • Tyrosine kinase inhibitor.
  • Antagonizes P-glycoprotein (P-gp) mediated multidrug resistance (MDR) in non-small cell lung cancer (NSCLC).

Catalog No. 50-004-02795 Supplier Medchemexpress LLC Supplier No. HY19642A10MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Glesatinib hydrochloride is an orally active, potent dual inhibitor of MET and SMO. This tyrosine kinase inhibitor also antagonizes P-glycoprotein (P-gp) mediated multidrug resistance (MDR) in non-small cell lung cancer (NSCLC).

  • Orally active and potent MET/SMO dual inhibitor.
  • Tyrosine kinase inhibitor.
  • Antagonizes P-glycoprotein (P-gp) mediated multidrug resistance (MDR) in non-small cell lung cancer (NSCLC).

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.